IRIS

This research letter aims at highlighting the contribution of cardiologists in the management of primary hyperoxaluria type I (PH1), a disease with recent therapeutic innovation that can potentially change its natural history.

Oxalic Cardiomyopathy: Could it Influence Treatment Plans in Patients With Primary Hyperoxaluria Type 1?

Di Toro, Alessandro;Urtis, Mario;Pellegrini, Carlo;Smirnova, Alexandra;Valentini, Adele;Arbustini, Eloisa
2021-01-01

Abstract

This research letter aims at highlighting the contribution of cardiologists in the management of primary hyperoxaluria type I (PH1), a disease with recent therapeutic innovation that can potentially change its natural history.
2021
Cardiovascular & Respiratory Systems
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
sì
WOS:000689250400014
2-s2.0-85113269781
Esperti anonimi
Inglese
Internazionale
STAMPA
78
9
998
999
2
34242728
https://www.sciencedirect.com/science/article/pii/S0735109721055558?via=ihub
no
10
info:eu-repo/semantics/article
262
Di Toro, Alessandro; Urtis, Mario; Giuliani, Lorenzo; Pellegrini, Carlo; Smirnova, Alexandra; Galato, Raffaele; Valentini, Adele; Jallous, Hussein; Sc...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
none
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1516095
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 6
social impact